论文部分内容阅读
目的:观察氨溴索佐治哮喘性支气管炎的实际效果。方法:选取2013年3月至2015年1月我院收治的哮喘性支气管炎患者56例,按硬币法将其分成实验组28例,对照组28例,对照组应用抗感染、平喘、解痉等常规治疗措施,实验组在对照组治疗的基础上应用氨溴索治疗,比较两组哮喘性支气管炎治疗效果。结果:实验组哮喘性支气管炎疾病治疗有效率为92.9%,咳嗽缓解时间为(4.23±1.32)d,喘息缓解时间为(3.85±1.21)d,与对照组比较,差异有统计学意义(P<0.05)。结论:氨溴索佐治哮喘性支气管炎,效果满意,值得进一步应用、推广。
Objective: To observe the actual effect of ambroxol on asthmatic bronchitis. Methods: From March 2013 to January 2015, 56 patients with asthmatic bronchitis admitted to our hospital were divided into experimental group (28 cases) and control group (28 cases) by coin method. The control group was treated with anti-infective, antiasthmatic and anti-asthmatic solution Spasm and other conventional treatment measures, the experimental group in the control group based on the application of ambroxol treatment, the treatment of asthma bronchitis in both groups. Results: The effective rate of treatment for asthmatic bronchitis was 92.9% in the experimental group, 4.23 ± 1.32 days for cough, and 3.85 ± 1.21 days for wheezing. Compared with the control group, the difference was statistically significant (P <0.05). Conclusion: Ambroxol treatment of asthmatic bronchitis, with satisfactory results, is worth further application, promotion.